Mia's Feed
Medical News & Research

Gum Disease Bacterium Linked to Heart Rhythm Disorders

Gum Disease Bacterium Linked to Heart Rhythm Disorders

Share this article

Researchers identify Porphyromonas gingivalis, a bacteria from gum disease, as a key factor in the development of atrial fibrillation, highlighting the importance of oral health for heart health.

2 min read

A groundbreaking study from Hiroshima University has uncovered a surprising connection between oral health and heart rhythm conditions. Researchers have found that the bacterium Porphyromonas gingivalis, commonly associated with gum disease (periodontitis), can enter the bloodstream and reach the heart, where it promotes scar tissue formation and disrupts normal electrical activity. This infiltration increases the likelihood of atrial fibrillation (AFib), a serious arrhythmia that raises the risk of stroke and heart failure.

Clinicians have long observed that individuals with gum disease are more prone to cardiovascular problems. Meta-analyses reveal that periodontitis can elevate the risk of developing AFib by about 30%. The global incidence of AFib has surged in recent years, nearly doubling from 33.5 million cases in 2010 to around 60 million in 2019, prompting investigations into potential causes including the role of oral bacteria.

Inflammation from gum infections can lead immune cells to release chemical signals into the bloodstream, causing systemic inflammation that harms various organs. Notably, DNA from bacteria like P. gingivalis has been detected in heart tissues, vascular plaques, and even brain tissue, implicating it in multiple systemic diseases.

This new research provides direct evidence of P. gingivalis migrating from the gums to the heart’s left atrium in both animal models and humans. Using a mouse model infected with the bacterium, scientists observed that the bacteria could invade the heart tissue, leading to increased fibrosis and abnormal heart rhythms over time. The bacteria's presence correlated with more significant scar tissue formation, which impairs electrical conduction.

In human samples, P. gingivalis DNA was identified in the left atrial tissue of patients with AFib, especially those with severe gum disease. The bacteria’s ability to hide inside cells and evade immune defenses may contribute to persistent inflammation and tissue damage.

The findings suggest that maintaining good oral hygiene through regular brushing, flossing, and dental checkups might help prevent bacteria from entering the bloodstream and affecting the heart. Preventive dental care could thus be a crucial strategy in reducing AFib risk.

Dr. Miyauchi emphasized that periodontal treatment might play an important role in preventing and managing AFib by blocking the pathway for bacterial translocation into the heart. Moving forward, the team aims to deepen the understanding of how P. gingivalis impacts cardiac cells and to foster collaboration between dental and medical professionals to improve cardiovascular health.

Source: https://medicalxpress.com/news/2025-05-heart-rhythm-disorder-bacterium-lurking.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Osteoporosis Treatment Benefits for Individuals Over 80 Years Old

New research suggests that osteoporosis treatment for individuals over 80 who suffer fractures can significantly reduce hospitalization and mortality, emphasizing the importance of personalized care in aging populations.

Genetic Markers Predict Immunotherapy Response in Melanoma Patients

Researchers have identified four genes that can predict how melanoma patients will respond to immunotherapy, paving the way for personalized treatment approaches and improved outcomes.

Why the ALS Drug BIIB078 Failed Despite Target Engagement

A groundbreaking study explains why the promising ALS drug BIIB078 failed despite reaching its target in the CNS. The research highlights the challenges in drug delivery and the need for better biomarkers to measure treatment effectiveness in ALS. Source: Emory University.

Innovative Portable Device Detects Rare Genetic Mutations Quickly and Accurately

A groundbreaking portable device developed by Rutgers engineers can detect rare genetic mutations from a single blood drop within 10 minutes, revolutionizing disease diagnosis and healthcare access.